EUVIMEDEUVIMED entdecken
Crossref

Empowering patients with tuberculosis to build public trust in treatment outcome data.

Luz Quevedo Cruz, Rosario Montoya, Carlos Pozo, Adelina Lozano, Eric Ramos, Lenin Bernaola, Jonathan Gómez, Maribel Rivero, Carlton Evans, Sumona Datta

The Global Health Network Collections · 16.06.2023

DOI: 10.21428/3d48c34a.1647ef50 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Global Health Network Collections, online erschienen am 16.06.2023. Verfasst von Luz Quevedo Cruz und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberculosis has killed more people than any other infection since records began. According to World Health Organization policy and global practice, tuberculosis treatment outcomes are reported as “good” if patients complete all their treatment without persisting positive laboratory tests; or “bad” if treatment is not completed, and/or laboratory tests remain positive. Globally, most patients treated for tuberculosis never have any positive laboratory test, so usually treatment outcome simply assesses whether patients have completed their standardised course of treatment. In an ongoing cohort of 15,000 patients with tuberculosis disease treated in 32 Peruvian shantytowns we have compared programmatic and patient-reported outcomes. Amongst 2152 consecutive patients with tuberculosis, half of the 6.1% of patients whose treatment outcome was “bad” because of death during treatment actually died from unrelated causes, so “good” tuberculosis outcomes were underestimated. Furthermore, patients who die after completing tuberculosis therapy are not included in outcome data, but verbal autopsies defined their cause of death to be tuberculosis for 25% (15/59), so “good” outcomes were overestimated. In a group of 1622 patients, 0.86% (14) were considered programmatically to have “bad” outcome because they were lost to follow-up, but our research team were able to contact them or their families in all but three cases and 91% (8/11) actually had good treatment outcomes, so “good” outcomes were underestimated. Similarly, we completed detailed follow-up for 607 patients who were considered to have had a “good” tuberculosis outcome, but 7.9% of them were diagnosed with tuberculosis again, so “good” outcomes were overestimated. We assessed wellbeing with the EUROHIS-QOL questionnaire for 836 patients after being considered to have had a good treatment outcome and 38% were not satisfied with their overall health, so “good” outcomes were overestimated. Because of these issues, patients with tuberculosis cannot be confident that current statistics indicate what health outcome to expect. We propose that global policy is changed to empower patients (or if they died, their relatives) to report several months after treatment ends their actual tuberculosis-related health, making tuberculosis treatment outcome statistics more meaningful.

Zitieren

APA

Cruz, L. Q., Montoya, R., Pozo, C., Lozano, A., Ramos, E., Bernaola, L., Gómez, J., Rivero, M., Evans, C., & Datta, S. (2023). Empowering patients with tuberculosis to build public trust in treatment outcome data. The Global Health Network Collections. https://doi.org/10.21428/3d48c34a.1647ef50

Vancouver

Cruz LQ, Montoya R, Pozo C, Lozano A, Ramos E, Bernaola L, et al. Empowering patients with tuberculosis to build public trust in treatment outcome data. The Global Health Network Collections. 2023. doi:10.21428/3d48c34a.1647ef50

BibTeX
@article{Cruz2023,
  author = {Cruz, Luz Quevedo and Montoya, Rosario and Pozo, Carlos and Lozano, Adelina and Ramos, Eric and Bernaola, Lenin and Gómez, Jonathan and Rivero, Maribel and Evans, Carlton and Datta, Sumona},
  title = {Empowering patients with tuberculosis to build public trust in treatment outcome data},
  journal = {The Global Health Network Collections},
  year = {2023},
  doi = {10.21428/3d48c34a.1647ef50}
}
Kostenlos starten →